Delivery Order SPE2DB22D2214-SPE2DB25FS6RT
- Not listed
- The Defense Logistics Agency awarded a $14,254.49 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a rheumatoid arthritis treatment administered via auto-injector. This competitively awarded, firm fixed-price delivery order was finalized on June 13, 2025, with an ultimate completion date of June 16, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a $17,548.12 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions. The contract, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $19,280.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis treatment. This non-set-aside contract was competitively awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls...
- The Defense Logistics Agency awarded a $19,295.10 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on September 3, 2025, with an ultimate completion date of September 4, 2025, indicating expedited fulfillment requirements. The product will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a $31,263.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract, which is a child order under a larger indefinite delivery contract vehicle, was competitively awarded without set-aside designation on May 7, 2025, with an ultimate completion date of May 8, 2025. The product will be delivered to...
- The Defense Logistics Agency awarded a $76,256.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued on a...
- The Defense Logistics Agency awarded a delivery order valued at $11,630.84 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a non-competitive award under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a $5,061.00 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed price contract was awarded on July 8, 2025, with an ultimate completion date of July 9, 2025, and represents a non-set-aside competitive award. The delivery order is being fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $11,053.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis treatment. The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive, non-set-aside delivery order executed through the company's existing DLA contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,954.49 by the Defense Logistics Agency (DLA) on September 23, 2025, for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price delivery order is set to be completed by September 24, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6RTDelivery Order
The Defense Logistics Agency awarded a $17,340.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This non-set-aside competitive award was issued on September 25, 2025, with an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The company's comprehensive SPE2DX contract vehicle enables the supply of a broad range of pharmaceutical products, medical devices, vaccines, and specialty medications across multiple therapeutic domains to support military healthcare programs globally. This delivery order for Orencia represents one of numerous small-to-moderate value transactions AmerisourceBergen executes under its prime vendor agreements with DLA, demonstrating the company's capability to fulfill specialized pharmaceutical requirements for federal healthcare customers on a competitive basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.3k | 9/25/25 |